Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Pertussis control: time for something new?

Clark TA, Messonnier NE, Hadler SC.

Trends Microbiol. 2012 May;20(5):211-3. doi: 10.1016/j.tim.2012.03.003. Epub 2012 Apr 9.

PMID:
22494804
2.

Acellular pertussis vaccines and pertussis resurgence: revise or replace?

Ausiello CM, Cassone A.

MBio. 2014 Jun 10;5(3):e01339-14. doi: 10.1128/mBio.01339-14.

3.

Development of improved vaccines against whooping cough: current status.

Marzouqi I, Richmond P, Fry S, Wetherall J, Mukkur T.

Hum Vaccin. 2010 Jul;6(7):543-53. Epub 2010 Jul 1. Review.

PMID:
20448470
4.

Do we need a new vaccine to control the re-emergence of pertussis?

Mills KH, Ross PJ, Allen AC, Wilk MM.

Trends Microbiol. 2014 Feb;22(2):49-52. doi: 10.1016/j.tim.2013.11.007.

PMID:
24485284
5.

Is there a need for a new generation of vaccines against pertussis?

Storsaeter J, Wolter J.

Expert Opin Emerg Drugs. 2006 May;11(2):195-205. Review.

PMID:
16634696
6.

Pertussis vaccines: state-of-the-art and future trends.

Tefon BE, Özcengiz E, Özcengiz G.

Curr Top Med Chem. 2013;13(20):2581-96. Review.

PMID:
24066885
7.

Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.

Hegerle N, Guiso N.

Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23. Review.

PMID:
24953157
8.

Resurgence of pertussis calls for re-evaluation of pertussis animal models.

van der Ark AA, Hozbor DF, Boog CJ, Metz B, van den Dobbelsteen GP, van Els CA.

Expert Rev Vaccines. 2012 Sep;11(9):1121-37. doi: 10.1586/erv.12.83. Review.

PMID:
23151168
9.

Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.

Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He Q, van der Heide HG, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan R, Lutyńska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RS, Xu Y, Yao SM, Zhang S, Parkhill J, Mooi FR.

MBio. 2014 Apr 22;5(2):e01074. doi: 10.1128/mBio.01074-14.

10.

Pertussis: challenges today and for the future.

Cherry JD.

PLoS Pathog. 2013;9(7):e1003418. doi: 10.1371/journal.ppat.1003418. Epub 2013 Jul 25. No abstract available.

11.

Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen.

Mooi FR.

Infect Genet Evol. 2010 Jan;10(1):36-49. doi: 10.1016/j.meegid.2009.10.007. Epub 2009 Oct 30. Review.

PMID:
19879977
12.

What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

Bolotin S, Harvill ET, Crowcroft NS.

Pathog Dis. 2015 Nov;73(8):ftv057. doi: 10.1093/femspd/ftv057. Epub 2015 Aug 6. Review.

PMID:
26253079
13.

Re-emergence of pertussis: what are the solutions?

Libster R, Edwards KM.

Expert Rev Vaccines. 2012 Nov;11(11):1331-46. doi: 10.1586/erv.12.118. Review. Erratum in: Expert Rev Vaccines. 2013 Feb;12(2):240-2.

PMID:
23249233
14.

Which strategy for pertussis vaccination today?

Girard DZ.

Paediatr Drugs. 2002;4(5):299-313. Review.

PMID:
11994035
15.

Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

[No authors listed]

MMWR Recomm Rep. 1997 Mar 28;46(RR-7):1-25. Erratum in: MMWR Morb Mortal Wkly Rep 1997 Aug 1;46(30):706.

16.

Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended?

Edwards KM.

Clin Infect Dis. 2001 Jun 15;32(12):1698-9. Epub 2001 May 21. No abstract available.

17.

Why do pertussis vaccines fail?

Cherry JD.

Pediatrics. 2012 May;129(5):968-70. doi: 10.1542/peds.2011-2594. Epub 2012 Apr 23. No abstract available.

18.

Whither pertussis?

Snelling TL, Waddington CS.

Expert Rev Anti Infect Ther. 2015 Feb;13(2):145-8. doi: 10.1586/14787210.2015.986462. Epub 2014 Nov 26.

PMID:
25426699
19.

Licensed pertussis vaccines in the United States. History and current state.

Klein NP.

Hum Vaccin Immunother. 2014;10(9):2684-90. doi: 10.4161/hv.29576. Epub 2014 Nov 6. Review.

20.

A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.

Dunne A, Mielke LA, Allen AC, Sutton CE, Higgs R, Cunningham CC, Higgins SC, Mills KH.

Mucosal Immunol. 2015 May;8(3):607-17. doi: 10.1038/mi.2014.93. Epub 2014 Oct 15.

PMID:
25315966
Items per page

Supplemental Content

Write to the Help Desk